BCL2 and lung adenocarcinoma: STAT3 phosphorylation inhibitor (Cryptotanshinone, MCE, USA) suppressed STAT3 (Tyr705) phosphorylation and then downregulated Bcl-2 and Survivin expression in lung adenocarcinoma cells.